{"id":245122,"date":"2026-10-09T05:06:41","date_gmt":"2026-10-09T10:06:41","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/10\/ten-years-of-ocrelizumab-in-relapsing-multiple-sclerosis-the-opera-i-and-ii-randomized-clinical-trials"},"modified":"2026-10-09T05:06:41","modified_gmt":"2026-10-09T10:06:41","slug":"ten-years-of-ocrelizumab-in-relapsing-multiple-sclerosis-the-opera-i-and-ii-randomized-clinical-trials","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/10\/ten-years-of-ocrelizumab-in-relapsing-multiple-sclerosis-the-opera-i-and-ii-randomized-clinical-trials","title":{"rendered":"Ten Years of Ocrelizumab in Relapsing Multiple Sclerosis: The OPERA I and II Randomized Clinical Trials"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/ten-years-of-ocrelizumab-in-relapsing-multiple-sclerosis-the-opera-i-and-ii-randomized-clinical-trials.png\"><\/a><\/p>\n<p>The open-label extension of the OPERA I and II randomized clinical trials assesses 10-year safety and efficacy of ocrelizumab in patients with relapsing multiple sclerosis.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The open-label extension of the OPERA I and II randomized clinical trials assesses 10-year safety and efficacy of ocrelizumab in patients with relapsing multiple sclerosis.<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-245122","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/245122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=245122"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/245122\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=245122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=245122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=245122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}